[시장보고서]폐부종 치료제 시장(2024-2028년)

폐부종 치료제 시장(2024-2028년)

Global pulmonary edema therapeutics market 2024-2028

상품코드 : 1524774 해당 상품은 즉시 배송 가능합니다

리서치사 : TechNavio

발행일 : 2024년 07월

페이지 정보 : 영문 145 Pages

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

폐부종 치료제 시장은 2023년부터 2028년까지 3억 6,550만 달러, 예측 기간 동안 3.27%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 폐부종 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 위험 요소의 높은 유병률, 노인 인구의 증가, 폐부종에 대한 인식의 증가에 의해 주도되고 있습니다.

시장 범위
기준 연도	2024
종료 연도	2028
예측 기간	2024-2028
성장 모멘텀	가속
전년 대비 2024년	3.13%
CAGR	3.27%
증분 금액	3억 6,550만 달러

이 보고서는 향후 몇 년간 폐부종 치료제 시장 성장을 주도할 주요 요인 중 하나로 질병 진단을 위한 바이오마커의 활용 증가를 꼽았습니다. 또한, 전략적 제휴와 호흡기 질환 관련 연구에 대한 자금 지원 증가가 시장의 큰 수요를 견인할 것으로 예상됩니다.

지역별 세분화
지역별 비교
북미 : 시장 규모와 예측 2023-2028
유럽 : 시장 규모와 예측 2023-2028
아시아 : 시장 규모와 예측 2023-2028
세계 기타 지역 : 시장 규모와 예측 2023-2028
미국 : 시장 규모와 예측 2023-2028
독일 : 시장 규모와 예측 2023-2028
영국 : 시장 규모와 예측 2023-2028
중국 : 시장 규모와 예측 2023-2028
캐나다 : 시장 규모와 예측 2023-2028
시장 기회 : 지역 상황별

제9장 촉진요인, 과제, 기회, 억제요인

시장 성장 촉진요인
시장 과제
성장 촉진요인과 과제의 영향
시장 기회·억제요인

제10장 경쟁 상황

개요
경쟁 상황
혼란 상황
업계 리스크

제11장 경쟁 분석

기업 개요
기업의 시장 포지셔닝
AbbVie Inc.
ADVANZ PHARMA
Apotex Inc.
Bausch Health Companies Inc.
Johnson and Johnson Services Inc.
Lupin Ltd.
Novartis AG
Pfizer Inc.
Sanofi SA
Teva Pharmaceutical Industries Ltd.

제12장 부록

ksm

영문 목차

영문목차

The pulmonary edema therapeutics market is forecasted to grow by USD 365.5 mn during 2023-2028, accelerating at a CAGR of 3.27% during the forecast period. The report on the pulmonary edema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of risk factors, increasing geriatric population, and growing awareness about pulmonary edema.

Technavio's pulmonary edema therapeutics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	3.13%
CAGR	3.27%
Incremental Value	$365.5mn

By Type

Cardiogenic pulmonary edema
Non-cardiogenic pulmonary edema

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing use of biomarkers for disease diagnosis as one of the prime reasons driving the pulmonary edema therapeutics market growth during the next few years. Also, strategic alliances and increase in funding for research on respiratory diseases will lead to sizable demand in the market.

The report on the pulmonary edema therapeutics market covers the following areas:

Pulmonary edema therapeutics market sizing
Pulmonary edema therapeutics market forecast
Pulmonary edema therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pulmonary edema therapeutics market vendors that include AbbVie Inc., ADVANZ PHARMA, Apotex Inc., Bausch Health Companies Inc., Baxter International Inc., CHIESI Farmaceutici SpA, CMP Pharma Inc., Emcure Pharmaceuticals Ltd., Epic Pharma LLC, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Shanghai Fosun Pharmaceutical Group Co. Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, and Viatris Inc.. Also, the pulmonary edema therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Pulmonary Edema Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Pulmonary Edema Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Cardiogenic pulmonary edema - Market size and forecast 2023-2028
- Chart on Cardiogenic pulmonary edema - Market size and forecast 2023-2028 ($ million)
- Data Table on Cardiogenic pulmonary edema - Market size and forecast 2023-2028 ($ million)
- Chart on Cardiogenic pulmonary edema - Year-over-year growth 2023-2028 (%)
- Data Table on Cardiogenic pulmonary edema - Year-over-year growth 2023-2028 (%)
6.4 Non-cardiogenic pulmonary edema - Market size and forecast 2023-2028
- Chart on Non-cardiogenic pulmonary edema - Market size and forecast 2023-2028 ($ million)
- Data Table on Non-cardiogenic pulmonary edema - Market size and forecast 2023-2028 ($ million)
- Chart on Non-cardiogenic pulmonary edema - Year-over-year growth 2023-2028 (%)
- Data Table on Non-cardiogenic pulmonary edema - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
11.4 ADVANZ PHARMA
- ADVANZ PHARMA - Overview
- ADVANZ PHARMA - Product / Service
- ADVANZ PHARMA - Key offerings
11.5 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
11.6 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
11.7 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
11.8 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Product / Service
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
11.9 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
11.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.11 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
11.12 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

한글목차

목차

제1장 주요 요약

제2장 시장 상황

제3장 시장 규모 평가

제4장 시장 규모 실적

제5장 Five Forces 분석

제6장 시장 세분화 : 유형별

제7장 고객 상황

제8장 지역별 상황